JOHNSON & JOHNSON
JOHNSON & JOHNSON
Aktie · US4781601046 · JNJ · 853260 (XNYS)
Übersicht
Kein Kurs
12.09.2025 21:32
1 Tag
-
1 Woche
-
1 Monat
-
3 Monate
-
6 Monate
-
Jahr bis heute
-
1 Jahr
-
2 Jahre
-
3 Jahre
-
4 Jahre
-
5 Jahre
-
10 Jahre
-
20 Jahre
-
Max
-
Analyst Grade Summary
gauge-img
Halten
Starker Kauf
Kaufen
Halten
Verkaufen
Starker Verkauf
0
16
18
3
0
Aktuelle Kurse von JOHNSON & JOHNSON
BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNYS: NYSE
NYSE
JNJ
USD
12.09.2025 21:32
178,20 USD
-0,30 USD
-0,17 %
XETR: XETRA
XETRA
JNJ.DE
EUR
12.09.2025 15:09
152,14 EUR
0,72 EUR
+0,48 %
ESG-Risiko-Rating
B+ Gering
Free Float & Liquidität
Free Float 99,87 %
Shares Float 2,41 B
Ausstehende Aktien 2,41 B
Investierte Fonds

Folgende Fonds haben in JOHNSON & JOHNSON investiert:

Fonds
iShares MSCI USA Islamic UCITS ETF USD (Dist)
Vol. in Mio
11.885,14
Anteil (%)
7,11 %
Fonds
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. in Mio
21.456,84
Anteil (%)
5,88 %
Fonds
iShares MSCI World Quality Dividend UCITS ETF USD (Acc)
Vol. in Mio
1.867,23
Anteil (%)
3,92 %
Fonds
iShares MSCI World Islamic UCITS ETF USD (Dist)
Vol. in Mio
12.780,82
Anteil (%)
3,89 %
Fonds
iShares Dow Jones Industrial Average UCITS ETF (DE)
Vol. in Mio
8.737,62
Anteil (%)
3,24 %
Firmenprofil zu JOHNSON & JOHNSON Aktie
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Unternehmensdaten

Name JOHNSON & JOHNSON
Firma Johnson & Johnson
Symbol JNJ
Website https://www.jnj.com
Heimatbörse XNYS NYSE
WKN 853260
ISIN US4781601046
Wertpapierart Aktie
Sektor Healthcare
Branche Drug Manufacturers - General
CEO Joaquin Duato
Marktkapitalisierung 356 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 138,1 T
Adresse One Johnson & Johnson Plaza, 08933 New Brunswick
IPO Datum 2007-12-28
Dividenden von 'JOHNSON & JOHNSON'
Ex-Datum Dividende pro Aktie
26.08.2025 1,30 USD
27.05.2025 1,30 USD
18.02.2025 1,24 USD
26.11.2024 1,24 USD
27.08.2024 1,24 USD
20.05.2024 1,24 USD
16.02.2024 1,19 USD
20.11.2023 1,19 USD
25.08.2023 1,19 USD
22.05.2023 1,19 USD

Aktien-Splits

Datum Split
13.06.2001 2:1
12.06.1996 2:1
10.06.1992 2:1
11.05.1989 2:1
19.05.1981 3:1
18.05.1970 3:1
19.06.1967 3:1

Ticker Symbole

Name Symbol
Frankfurt JNJ.F
NYSE JNJ
XETRA JNJ.DE
Weitere Aktien
Investoren, die JOHNSON & JOHNSON halten, haben auch folgende Aktien im Depot:
ALLIANZ AG
ALLIANZ AG Aktie
AMAZON.CO INC
AMAZON.CO INC Aktie
APPLE INC
APPLE INC Aktie
COCA-COLA CO
COCA-COLA CO Aktie
DAX
DAX Index
DZ BANK      IS.A2944
DZ BANK IS.A2944 Anleihe
FTSE 100 UCITS ETF - (GBP) DISTRIBUTING
FTSE 100 UCITS ETF - (GBP) DISTRIBUTING ETF
MCDONALDS CORP
MCDONALDS CORP Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
PROCTER GAMBLE CORP
PROCTER GAMBLE CORP Aktie
PT Indonesia Kendaraan Terminal Tbk
PT Indonesia Kendaraan Terminal Tbk Aktie
TESLA INC
TESLA INC Aktie
UNILEVER PLC
UNILEVER PLC Aktie
VISA INC - CLASS A
VISA INC - CLASS A Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025